Cargando…

The role of immunotherapy in non-clear cell renal cell carcinoma

The category of non-clear cell renal cell carcinoma (nccRCC) includes several clinically, histologically, and molecularly diverse entities. Traditionally, they comprise type 1 and type 2 papillary, chromophobe, unclassified, and other histologies (medullary, collecting duct carcinoma, and translocat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Climent, Carla, Soriano, Sandra, Bonfill, Teresa, Lopez, Natalia, Rodriguez, Marta, Sierra, Marina, Andreu, Pablo, Fragio, Monica, Busquets, Mireia, Carrasco, Alicia, Cano, Ona, Seguí, Miguel-Angel, Gallardo, Enrique
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9936973/ https://www.ncbi.nlm.nih.gov/pubmed/36816976 http://dx.doi.org/10.3389/fonc.2023.941835

Ejemplares similares

Teleoncology: A Solution for Everyone? A Single-Center Experience with Telemedicine during the Coronavirus Disease 2019 (COVID-19) Pandemic
por: Ribera, Paula, et al.
Publicado: (2022)

Molecular Mechanisms of Resistance to Immunotherapy and Antiangiogenic Treatments in Clear Cell Renal Cell Carcinoma
por: Ballesteros, Pablo Álvarez, et al.
Publicado: (2021)

The Changing Pattern of Non-Small Cell Lung Cancer Between the 90(th) and 2000(th) Decades
por: Montesinos, Jesus, et al.
Publicado: (2011)

Updates on Immunotherapy and Immune Landscape in Renal Clear Cell Carcinoma
por: Kim, Myung-Chul, et al.
Publicado: (2021)

EMILIN2 is associated with prognosis and immunotherapy in clear cell renal cell carcinoma
por: Zhao, Guangjian, et al.
Publicado: (2022)

Revisiting mechanisms of resistance to immunotherapies in metastatic clear-cell renal-cell carcinoma
por: Chatwal, Monica Sheila, et al.
Publicado: (2023)

Landscape of immune cell infiltration in clear cell renal cell carcinoma to aid immunotherapy
por: Bai, Dan, et al.
Publicado: (2021)

Integrated Analysis Of Immunotherapy Treated Clear Cell Renal Cell Carcinomas: An Exploratory Study
por: Sobottka, Bettina, et al.
Publicado: (2022)

Immunotherapy: A new standard in the treatment of metastatic clear cell renal cell carcinoma
por: Popovic, Maja, et al.
Publicado: (2022)

Decoding the Immune Microenvironment of Clear Cell Renal Cell Carcinoma by Single-Cell Profiling to Aid Immunotherapy
por: Liu, Jie, et al.
Publicado: (2022)

Identification of immune subtypes to guide immunotherapy and targeted therapy in clear cell renal cell carcinoma
por: Xu, Chen, et al.
Publicado: (2022)

Immunotherapy and Immune Infiltration in Patients with Clear Cell Renal Cell Carcinoma: A Comprehensive Analysis
por: Hou, Lin, et al.
Publicado: (2023)

TLR4 predicts patient prognosis and immunotherapy efficacy in clear cell renal cell carcinoma
por: Zhang, Zhentao, et al.
Publicado: (2023)

Immune-related risk prognostic model for clear cell renal cell carcinoma: Implications for immunotherapy
por: Chen, Ronghui, et al.
Publicado: (2023)

Optimal management of cancer anorexia–cachexia syndrome
por: Argilés, Josep M, et al.
Publicado: (2010)

Regenerative potential of allogeneic adipose tissue-derived mesenchymal cells in canine cutaneous wounds
por: Enciso, Nathaly, et al.
Publicado: (2020)

Potential Application of Pyroptosis in Kidney Renal Clear Cell Carcinoma Immunotherapy and Targeted Therapy
por: Qi, Xiaochen, et al.
Publicado: (2022)

Bioinformatics analysis of immune-related prognostic genes and immunotherapy in renal clear cell carcinoma
por: Pan, Ziwen, et al.
Publicado: (2022)

Case report: Robust response of metastatic clear cell sarcoma treated with cabozantinib and immunotherapy
por: Sidlik Muskatel, Rakefet, et al.
Publicado: (2022)

Characterization of Molecular Heterogeneity Associated With Tumor Microenvironment in Clear Cell Renal Cell Carcinoma to Aid Immunotherapy
por: Zhong, Weimin, et al.
Publicado: (2021)

Prognosis-related genes participate in immunotherapy of renal clear cell carcinoma possibly by targeting dendritic cells
por: Fang, Guodong, et al.
Publicado: (2022)

Is Adjuvant Immunotherapy Worth for All Patients with Clear-cell Renal Cell Carcinoma at High Risk of Recurrence?
por: Marchioni, Michele, et al.
Publicado: (2022)

Identification of immunogenic cell death-related signature on prognosis and immunotherapy in kidney renal clear cell carcinoma
por: Jiang, Silin, et al.
Publicado: (2023)

Targeting β2-Adrenergic Receptors Shows Therapeutical Benefits in Clear Cell Renal Cell Carcinoma from Von Hippel–Lindau Disease
por: Albiñana, Virginia, et al.
Publicado: (2020)

Proteomics Characterization of Clear Cell Renal Cell Carcinoma
por: Miranda-Poma, Jesús, et al.
Publicado: (2023)

Leveraging diverse cell-death patterns to predict the prognosis, immunotherapy and drug sensitivity of clear cell renal cell carcinoma
por: Zhang, Xi, et al.
Publicado: (2023)

Ubiquitin Modification Patterns of Clear Cell Renal Cell Carcinoma and the Ubiquitin Score to Aid Immunotherapy and Targeted Therapy
por: Zhou, Peng, et al.
Publicado: (2021)

The Frontline Immunotherapy-Based Treatment of Advanced Clear Cell Renal Cell Carcinoma: Current Evidence and Clinical Perspective
por: Kim, In-Ho, et al.
Publicado: (2022)

SPI1 is a prognostic biomarker of immune infiltration and immunotherapy efficacy in clear cell renal cell carcinoma
por: Feng, Huayi, et al.
Publicado: (2022)

An immunogenic cell death-related classification predicts prognosis and response to immunotherapy in kidney renal clear cell carcinoma
por: Wang, Licheng, et al.
Publicado: (2023)

Silencing of genes by promoter hypermethylation shapes tumor microenvironment and resistance to immunotherapy in clear-cell renal cell carcinomas
por: Lu, Xiaofan, et al.
Publicado: (2023)

Natural Killer Cells in Immunotherapy: Are We Nearly There?
por: Bachiller, Mireia, et al.
Publicado: (2020)

Effect of Cancer-Related Cachexia and Associated Changes in Nutritional Status, Inflammatory Status, and Muscle Mass on Immunotherapy Efficacy and Survival in Patients with Advanced Non-Small Cell Lung Cancer
por: Madeddu, Clelia, et al.
Publicado: (2023)

1641P Patient preferences towards the application of telemedicine on cancer care during Coronavirus disease 2019 (COVID-19) pandemic. ONCOTELEMED STUDY
por: Ribera, P., et al.
Publicado: (2021)

1638P Experience with telemedicine during COVID-19 pandemic
por: Soriano, S., et al.
Publicado: (2021)

Novel immune‐related signature based on immune cells for predicting prognosis and immunotherapy response in clear cell renal cell carcinoma
por: Zhou, Libin, et al.
Publicado: (2022)

Bispecific Antibody Format and the Organization of Immunological Synapses in T Cell-Redirecting Strategies for Cancer Immunotherapy
por: Carrasco-Padilla, Carlos, et al.
Publicado: (2022)

Identification of an immunogenic cell death-related gene signature predicts survival and sensitivity to immunotherapy in clear cell renal carcinoma
por: Zhou, Shuoming, et al.
Publicado: (2023)

Prognostic prediction and immunotherapy response analysis of the fatty acid metabolism-related genes in clear cell renal cell carcinoma
por: Yao, Qinfan, et al.
Publicado: (2023)

A novel immune-related gene signature for predicting immunotherapy outcomes and survival in clear cell renal cell carcinoma
por: Gu, Jie, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rnl71egstn07k2osdnuii056ig